A 2007 double-blind, multicenter trial (n=102) showed ALC 1,500 mg/day significantly improved tender point count, total myalgic score, depression, and musculoskeletal pain compared to placebo.[9] A 2015 RCT found ALC 1,500 mg/day comparable to duloxetine 60 mg/day for pain and depression.[8] Most notably, a 2023 RCT demonstrated that adding PEA 1,200 mg/day + ALC 2,000 mg/day to ongoing duloxetine + pregabalin therapy produced significantly greater improvements in Widespread Pain Index, FIQR, and FASmod scores.[7] Role in Treatment: ALC can be used as monotherapy or adjunctive therapy in fibromyalgia
This can manifest as mild puffiness in the hands, feet, or face, particularly in the first 2 to 4 weeks
Ongoing Support Current States Serviced by Pharmacy Pharmacy Partner #1 Does NOT ship Weight loss Medication to Alabama, Arkansas, California, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, New Jersey, New Mexico, Ohio, Washington, West Virginia Pharmacy Partner #2 Does NOT ship to Iowa, Massachusetts, Wisconsin ,New Jersey, New Mexico, Massachutsess, Ohio, Washington, West Virginia, California Pharmacy Partner #3 Does NOT ship to Alabama, Arkansas, California, Kentucky, South Carolina
Consumption of flavonoids in onions and black tea: lack of effect on F 2 -isoprostanes and autoantibodies to oxidized LDL in healthy humans
